menu
    • menu
    [{"orgOrder":0,"company":"KIMBERLY CLARK HEALTH CARE","sponsor":"KIMBERLY CLARK HEALTH CARE","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2016","type":"Inapplicable","leadProduct":"Estradiol","moa":"estrogens","graph1":"Urology","graph2":"Phase IV","graph3":"KIMBERLY CLARK HEALTH CARE","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Cream","sponsorNew":"KIMBERLY CLARK HEALTH CARE \/ KIMBERLY CLARK HEALTH CARE","highestDevelopmentStatusID":"11","companyTruncated":"KIMBERLY CLARK HEALTH CARE \/ KIMBERLY CLARK HEALTH CARE"},{"orgOrder":0,"company":"KIMBERLY CLARK HEALTH CARE","sponsor":"Sorrento Therapeutics","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2017","type":"Inapplicable","leadProduct":"Sumatriptan","moa":"Serotonin 1b (5-HT1b) receptor | Serotonin 1d (5-HT1d) receptor","graph1":"Neurology","graph2":"Phase I","graph3":"KIMBERLY CLARK HEALTH CARE","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KIMBERLY CLARK HEALTH CARE \/ KIMBERLY CLARK HEALTH CARE","highestDevelopmentStatusID":"6","companyTruncated":"KIMBERLY CLARK HEALTH CARE \/ KIMBERLY CLARK HEALTH CARE"},{"orgOrder":0,"company":"KIMBERLY CLARK HEALTH CARE","sponsor":"London Health Sciences Centre Research Institute (Lawson) | Western University, Canada | Integrated Research","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"INDIA","productType":"Probiotic","year":"2014","type":"Inapplicable","leadProduct":"Lactobacillus","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase I","graph3":"KIMBERLY CLARK HEALTH CARE","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"KIMBERLY CLARK HEALTH CARE \/ London Health Sciences Centre Research Institute (Lawson) | Western University, Canada | Integrated Research","highestDevelopmentStatusID":"6","companyTruncated":"KIMBERLY CLARK HEALTH CARE \/ London Health Sciences Centre Research Institute (Lawson) | Western University, Canada | Integrated Research"}]

    Find Clinical Drug Pipeline Developments & Deals by KIMBERLY CLARK HEALTH CARE

    Menu

    KIMBERLY CLARK HEALTH CARE

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            KIMBERLY CLARK HEALTH CARE

                            India arrow
                            CTAD25
                            Not Confirmed

                            KIMBERLY CLARK HEALTH CARE

                            India arrow
                            CTAD25
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Sumatriptan

                            Therapeutic Area : Neurology

                            Study Phase : Phase I

                            Recipient : Sorrento Therapeutics

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002)

                            Details : Sumatriptan Succinate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Migraine Disorders.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            July 26, 2017

                            Lead Product(s) : Sumatriptan

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase I

                            Recipient : Sorrento Therapeutics

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            KIMBERLY CLARK HEALTH CARE

                            India arrow
                            CTAD25
                            Not Confirmed

                            KIMBERLY CLARK HEALTH CARE

                            India arrow
                            CTAD25
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Estradiol

                            Therapeutic Area : Urology

                            Study Phase : Phase IV

                            Recipient : Loyola University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Investigation of the Effect of the Female Urinary Microbiome on Incontinence

                            Details : Estrogen is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Urinary Bladder, Overactive.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            July 18, 2016

                            Lead Product(s) : Estradiol

                            Therapeutic Area : Urology

                            Highest Development Status : Phase IV

                            Recipient : Loyola University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            KIMBERLY CLARK HEALTH CARE

                            India arrow
                            CTAD25
                            Not Confirmed

                            KIMBERLY CLARK HEALTH CARE

                            India arrow
                            CTAD25
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lactobacillus

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase I

                            Sponsor : London Health Sciences Centre Research Institute (Lawson) | Western University, Canada | Integrated Research

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Exploratory Study to Evaluate the Effects of the Probiotics L. Rhamnosus GR-1 and L. Reuteri RC-14

                            Details : Lactobacillus is a Probiotic drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Vaginosis, Bacterial.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            May 15, 2014

                            Lead Product(s) : Lactobacillus

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase I

                            Sponsor : London Health Sciences Centre Research Institute (Lawson) | Western University, Canada | Integrated Research

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth